Urology - Physician - Director, Bladder Cancer and Robotic Cystectomy Program - Manhattan and Lo...

Mount Sinai; New York (NY); Presencial; USD 650 000 - 1 000 000; Tempo integral

Resumo da oferta

A leading healthcare institution in New York is seeking an academic urologic oncologist for the Director of the Bladder Cancer Program. This role involves providing strategic leadership, expanding clinical pathways, and leading innovative robotic surgery approaches. Candidates should have an MD, board certification in Urology, and a strong record in bladder cancer care. The compensation ranges from $650K to $1M, excluding bonuses and benefits, and reflects a commitment to transparency in salary disclosures.

Qualificações

• Eligible for faculty appointment at Associate Professor or Professor level.
• Strong record of clinical excellence, research productivity, and academic leadership.
• Demonstrated expertise in robotic cystectomy and complex urinary reconstruction.

Responsabilidades

• Provide strategic direction and operational leadership for the Bladder Cancer Program.
• Develop and lead clinical trials in bladder cancer.
• Expand patient access through regional and international referrals.

Conhecimentos

Robotic cystectomy

Complex urinary reconstruction

Leadership in clinical trials

Translational research initiatives

Formação académica

MD or equivalent medical degree

Board-certified or board-eligible in Urology

Fellowship training in Urologic Oncology

Descrição da oferta de emprego

Overview

The Department of Urology at Mount Sinai Health System is seeking an outstanding academic urologic oncologist to serve as Director of the Bladder Cancer Program and Director of the Robotic Cystectomy Program. The successful candidate will be recruited at the Associate Professor or Professor level depending on qualifications and academic accomplishments.

Mount Sinai is home to one of the leading bladder cancer programs in the United States and the #1 bladder cancer program in New York City, offering comprehensive, multidisciplinary care for patients with non muscle invasive and muscle invasive bladder cancer. The program integrates advanced diagnostics, clinical trials, precision oncology, and minimally invasive surgical innovation, including a highly developed robotic cystectomy platform. The incoming Director will provide clinical, academic, and strategic leadership to further expand the program’s regional, national, and international impact.

The search is open to outstanding candidates from the United States and internationally, with a strong track record in bladder cancer care, robotic surgery, research, and program leadership.

Responsibilities

• Program Leadership

• Provide strategic direction and operational leadership for the Bladder Cancer Program.

• Maintain and grow Mount Sinai’s position as a regional and national leader in bladder cancer care.

• Develop clinical pathways and quality metrics to ensure best-in-class patient outcomes.

• Robotic Cystectomy Program

• Lead and expand the robotic cystectomy program, including innovation in minimally invasive and reconstructive techniques.

• Standardize protocols for robotic radical cystectomy and urinary diversion.

• Mentor faculty and fellows in advanced robotic oncology surgery.

• Multidisciplinary Collaboration

• Work closely with medical oncology, radiation oncology, pathology, radiology, and translational research teams.

• Lead multidisciplinary bladder tumor boards and clinical program development.

• Research & Academic Leadership

• Develop and lead clinical trials in bladder cancer.

• Promote translational research initiatives in immunotherapy, biomarkers, and surgical innovation.

• Contribute to high-impact publications, federal grants, and national research collaborations.

• Education & Mentorship

• Train and mentor residents, fellows, and junior faculty.

• Develop educational initiatives in robotic bladder cancer surgery and oncologic management.

• Program Growth & Reputation

• Expand patient access through regional and international referrals.

• Represent Mount Sinai at national and international academic meetings.

• Collaborate with institutional leadership to strengthen Mount Sinai’s global reputation in bladder cancer care.

• Qualifications

• MD or equivalent medical degree.

• Board-certified or board-eligible in Urology (or international equivalent).

• Fellowship training in Urologic Oncology preferred.

• Demonstrated expertise in robotic cystectomy and complex urinary reconstruction.

• Strong record of clinical excellence, research productivity, and academic leadership.

• Eligible for faculty appointment at Associate Professor or Professor level.

Compensation range from 650K to 1M (not including bonuses / incentive compensation or benefits)

Salary Disclosure Information: Mount Sinai Health System provides a salary range to comply with the New York City law on Salary Transparency in Job Advertisements. Actual salaries depend on a variety of factors, including experience, specialties, historical productivity, historical collections, and hospital/community need. As such, an actual salary may fall closer to one or the other end of the range, and in certain circumstances, may wind up being outside of the listed salary range. The salary range listed is for full-time employment and does not include bonuses / incentive compensation or benefits.

Equal Opportunity Employer

The Mount Sinai Health System is an equal opportunity employer, complying with all applicable federal civil rights laws. We do not discriminate, exclude, or treat individuals differently based on race, color, national origin, age, religion, disability, sex, sexual orientation, gender, veteran status, or any other characteristic protected by law. We are deeply committed to fostering an environment where all faculty, staff, students, trainees, patients, visitors, and the communities we serve feel respected and supported. Our goal is to create a healthcare and learning institution that actively works to remove barriers, address challenges, and promote fairness in all aspects of our organization.